This study is being done to investigate whether screening for bladder cancer with a commonly available urinalysis (UA) and novel urine marker testing results in the detection of early stage bladder cancer.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT05646485.
Locations matching your search criteria
United States
Texas
Dallas
UT Southwestern/Simmons Cancer Center-DallasStatus: Active
Contact: Yair Lotan
Phone: 214-645-8787
PRIMARY OBJECTIVE:
I. To investigate the rates of bladder cancer detection among screened at-risk patients.
OUTLINE: This is an observational study.
Patients undergo urine sample collection on study. Patients with 3-25 red blood cells per high powered fields in the urine are referred to undergo cystoscopy or urine marker cancer testing on study. Patients' medical records are reviewed. Patients may also undergo ultrasound or computed tomography scans
Trial PhaseNo phase specified
Trial Typescreening
Lead OrganizationUT Southwestern/Simmons Cancer Center-Dallas
Principal InvestigatorYair Lotan
